nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—PTGFR—Small Ligand GPCRs—S1PR1—multiple sclerosis	0.0339	0.0685	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Small Ligand GPCRs—S1PR1—multiple sclerosis	0.0332	0.067	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Prostanoid ligand receptors—PTGER4—multiple sclerosis	0.0311	0.0629	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostanoid ligand receptors—PTGER4—multiple sclerosis	0.0305	0.0616	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Eicosanoid ligand-binding receptors—PTGER4—multiple sclerosis	0.0207	0.0418	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Eicosanoid ligand-binding receptors—PTGER4—multiple sclerosis	0.0203	0.0409	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Small Ligand GPCRs—PTGER4—multiple sclerosis	0.0171	0.0346	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Small Ligand GPCRs—PTGER4—multiple sclerosis	0.0168	0.0339	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Small Ligand GPCRs—CNR1—multiple sclerosis	0.0148	0.03	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Small Ligand GPCRs—CNR1—multiple sclerosis	0.0145	0.0294	CbGpPWpGaD
Carboprost Tromethamine—Dinoprostone—PTGER4—multiple sclerosis	0.0137	1	CrCbGaD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.0119	0.024	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.0116	0.0235	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Other—S1PR1—multiple sclerosis	0.00967	0.0196	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Other—CXCR3—multiple sclerosis	0.00472	0.00955	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00438	0.00886	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00429	0.00867	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Other—CNR1—multiple sclerosis	0.00424	0.00857	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.00392	0.00792	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.00384	0.00776	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.0036	0.00728	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00352	0.00712	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00339	0.00685	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00332	0.0067	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.0031	0.00626	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00303	0.00613	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Other—CCR5—multiple sclerosis	0.00296	0.00599	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.0029	0.00587	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00284	0.00574	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—S1PR1—multiple sclerosis	0.00274	0.00554	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—S1PR1—multiple sclerosis	0.00268	0.00543	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00265	0.00537	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00265	0.00537	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.0026	0.00525	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.0026	0.00525	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GPR65—multiple sclerosis	0.00221	0.00447	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GPR65—multiple sclerosis	0.00216	0.00437	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00213	0.0043	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00208	0.0042	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00205	0.00415	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCL13—multiple sclerosis	0.00202	0.00409	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCR1—multiple sclerosis	0.00202	0.00409	CbGpPWpGaD
Carboprost Tromethamine—Eye pain—Betamethasone—multiple sclerosis	0.00202	0.0041	CcSEcCtD
Carboprost Tromethamine—Eye pain—Dexamethasone—multiple sclerosis	0.00202	0.0041	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00201	0.00406	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.002	0.00404	CbGpPWpGaD
Carboprost Tromethamine—Urinary tract infection—Mitoxantrone—multiple sclerosis	0.00199	0.00405	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCL13—multiple sclerosis	0.00198	0.004	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCR1—multiple sclerosis	0.00198	0.004	CbGpPWpGaD
Carboprost Tromethamine—Infection—Cladribine—multiple sclerosis	0.00198	0.00402	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.00195	0.00395	CbGpPWpGaD
Carboprost Tromethamine—Pulmonary oedema—Prednisone—multiple sclerosis	0.00195	0.00396	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Cladribine—multiple sclerosis	0.00194	0.00395	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Cladribine—multiple sclerosis	0.00192	0.00391	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00189	0.00382	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.00188	0.00383	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.00188	0.00383	CcSEcCtD
Carboprost Tromethamine—Respiratory failure—Methotrexate—multiple sclerosis	0.00186	0.00378	CcSEcCtD
Carboprost Tromethamine—Lethargy—Dexamethasone—multiple sclerosis	0.00186	0.00378	CcSEcCtD
Carboprost Tromethamine—Lethargy—Betamethasone—multiple sclerosis	0.00186	0.00378	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00185	0.00374	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00184	0.00372	CbGpPWpGaD
Carboprost Tromethamine—Sweating increased—Prednisolone—multiple sclerosis	0.00184	0.00374	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00182	0.00368	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00181	0.00369	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.0018	0.00365	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Cladribine—multiple sclerosis	0.00179	0.00363	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00178	0.0036	CbGpPWpGaD
Carboprost Tromethamine—Dyspnoea—Cladribine—multiple sclerosis	0.00177	0.00361	CcSEcCtD
Carboprost Tromethamine—Somnolence—Cladribine—multiple sclerosis	0.00177	0.0036	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00176	0.00355	CbGpPWpGaD
Carboprost Tromethamine—Asthma—Triamcinolone—multiple sclerosis	0.00174	0.00353	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00172	0.00348	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00171	0.00346	CbGpPWpGaD
Carboprost Tromethamine—Pain—Cladribine—multiple sclerosis	0.0017	0.00346	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Triamcinolone—multiple sclerosis	0.00169	0.00344	CcSEcCtD
Carboprost Tromethamine—Myalgia—Azathioprine—multiple sclerosis	0.00169	0.00343	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Methylprednisolone—multiple sclerosis	0.00169	0.00343	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00167	0.00338	CbGpPWpGaD
Carboprost Tromethamine—Chills—Mitoxantrone—multiple sclerosis	0.00165	0.00336	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Methotrexate—multiple sclerosis	0.00163	0.00331	CcSEcCtD
Carboprost Tromethamine—Lethargy—Prednisone—multiple sclerosis	0.00162	0.00329	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.00161	0.00328	CcSEcCtD
Carboprost Tromethamine—Infection—Azathioprine—multiple sclerosis	0.00161	0.00327	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00158	0.00319	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Cladribine—multiple sclerosis	0.00157	0.0032	CcSEcCtD
Carboprost Tromethamine—Back pain—Mitoxantrone—multiple sclerosis	0.00155	0.00315	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00155	0.00313	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00155	0.00312	CbGpPWpGaD
Carboprost Tromethamine—Sweating increased—Betamethasone—multiple sclerosis	0.00153	0.00312	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Dexamethasone—multiple sclerosis	0.00153	0.00312	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00152	0.00307	CbGpPWpGaD
Carboprost Tromethamine—Vision blurred—Mitoxantrone—multiple sclerosis	0.00151	0.00307	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00147	0.003	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Cladribine—multiple sclerosis	0.00147	0.00298	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Triamcinolone—multiple sclerosis	0.00146	0.00297	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCL3—multiple sclerosis	0.00144	0.00291	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Cladribine—multiple sclerosis	0.00143	0.0029	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00142	0.00287	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCL3—multiple sclerosis	0.00141	0.00285	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—S1PR1—multiple sclerosis	0.00141	0.00284	CbGpPWpGaD
Carboprost Tromethamine—Cough—Mitoxantrone—multiple sclerosis	0.0014	0.00284	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00139	0.00281	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—PTGER4—multiple sclerosis	0.00139	0.0028	CbGpPWpGaD
Carboprost Tromethamine—Hypertension—Mitoxantrone—multiple sclerosis	0.00138	0.00281	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—S1PR1—multiple sclerosis	0.00138	0.00278	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.00137	0.00279	CcSEcCtD
Carboprost Tromethamine—Chest pain—Mitoxantrone—multiple sclerosis	0.00136	0.00278	CcSEcCtD
Carboprost Tromethamine—Myalgia—Mitoxantrone—multiple sclerosis	0.00136	0.00278	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Cladribine—multiple sclerosis	0.00136	0.00277	CcSEcCtD
Carboprost Tromethamine—Anxiety—Mitoxantrone—multiple sclerosis	0.00136	0.00277	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—PTGER4—multiple sclerosis	0.00136	0.00274	CbGpPWpGaD
Carboprost Tromethamine—Lethargy—Methotrexate—multiple sclerosis	0.00135	0.00275	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCR3—multiple sclerosis	0.00134	0.00271	CbGpPWpGaD
Carboprost Tromethamine—Sweating increased—Prednisone—multiple sclerosis	0.00134	0.00272	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—RGS1—multiple sclerosis	0.00132	0.00266	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Cladribine—multiple sclerosis	0.00132	0.00268	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCR3—multiple sclerosis	0.00131	0.00265	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00131	0.00266	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCR2—multiple sclerosis	0.0013	0.00263	CbGpPWpGaD
Carboprost Tromethamine—Infection—Mitoxantrone—multiple sclerosis	0.0013	0.00264	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—RGS1—multiple sclerosis	0.00129	0.00261	CbGpPWpGaD
Carboprost Tromethamine—Shock—Mitoxantrone—multiple sclerosis	0.00129	0.00262	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00129	0.0026	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Azathioprine—multiple sclerosis	0.00128	0.0026	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00128	0.0026	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCR2—multiple sclerosis	0.00128	0.00258	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Cladribine—multiple sclerosis	0.00127	0.00257	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00126	0.00257	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00126	0.00255	CbGpPWpGaD
Carboprost Tromethamine—Rash—Cladribine—multiple sclerosis	0.00125	0.00255	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Cladribine—multiple sclerosis	0.00125	0.00255	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GPR65—multiple sclerosis	0.00125	0.00252	CbGpPWpGaD
Carboprost Tromethamine—Headache—Cladribine—multiple sclerosis	0.00125	0.00254	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Prednisolone—multiple sclerosis	0.00124	0.00252	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00122	0.00247	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GPR65—multiple sclerosis	0.00122	0.00247	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CNR1—multiple sclerosis	0.0012	0.00243	CbGpPWpGaD
Carboprost Tromethamine—Angioedema—Prednisolone—multiple sclerosis	0.0012	0.00244	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.0012	0.00242	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—RGS1—multiple sclerosis	0.0012	0.00242	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Azathioprine—multiple sclerosis	0.00119	0.00242	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00119	0.00242	CcSEcCtD
Carboprost Tromethamine—Nausea—Cladribine—multiple sclerosis	0.00118	0.0024	CcSEcCtD
Carboprost Tromethamine—Vertigo—Prednisolone—multiple sclerosis	0.00118	0.0024	CcSEcCtD
Carboprost Tromethamine—Syncope—Prednisolone—multiple sclerosis	0.00118	0.0024	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CNR1—multiple sclerosis	0.00118	0.00238	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00117	0.00239	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—RGS1—multiple sclerosis	0.00117	0.00237	CbGpPWpGaD
Carboprost Tromethamine—Back pain—Triamcinolone—multiple sclerosis	0.00117	0.00238	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00117	0.00237	CcSEcCtD
Carboprost Tromethamine—Somnolence—Mitoxantrone—multiple sclerosis	0.00116	0.00237	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Prednisolone—multiple sclerosis	0.00116	0.00235	CcSEcCtD
Carboprost Tromethamine—Asthma—Methotrexate—multiple sclerosis	0.00115	0.00233	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCR1—multiple sclerosis	0.00114	0.00231	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00114	0.00231	CbGpPWpGaD
Carboprost Tromethamine—Hypertension—Prednisolone—multiple sclerosis	0.00114	0.00231	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GPR65—multiple sclerosis	0.00113	0.00229	CbGpPWpGaD
Carboprost Tromethamine—Pain—Mitoxantrone—multiple sclerosis	0.00112	0.00228	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCR1—multiple sclerosis	0.00112	0.00226	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00112	0.00226	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GPR65—multiple sclerosis	0.00111	0.00224	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Azathioprine—multiple sclerosis	0.00111	0.00225	CcSEcCtD
Carboprost Tromethamine—Angioedema—Triamcinolone—multiple sclerosis	0.0011	0.00225	CcSEcCtD
Carboprost Tromethamine—Angioedema—Methylprednisolone—multiple sclerosis	0.0011	0.00224	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.0011	0.00223	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LINGO1—multiple sclerosis	0.0011	0.00222	CbGpPWpGaD
Carboprost Tromethamine—Vertigo—Triamcinolone—multiple sclerosis	0.00109	0.00221	CcSEcCtD
Carboprost Tromethamine—Syncope—Triamcinolone—multiple sclerosis	0.00108	0.00221	CcSEcCtD
Carboprost Tromethamine—Vertigo—Methylprednisolone—multiple sclerosis	0.00108	0.0022	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCL10—multiple sclerosis	0.00108	0.00219	CbGpPWpGaD
Carboprost Tromethamine—Syncope—Methylprednisolone—multiple sclerosis	0.00108	0.0022	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00108	0.00218	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LINGO1—multiple sclerosis	0.00107	0.00217	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00107	0.00218	CcSEcCtD
Carboprost Tromethamine—Dizziness—Azathioprine—multiple sclerosis	0.00107	0.00218	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.00107	0.00217	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00106	0.00216	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00106	0.00216	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00106	0.00214	CbGpPWpGaD
Carboprost Tromethamine—Shock—Prednisolone—multiple sclerosis	0.00106	0.00215	CcSEcCtD
Carboprost Tromethamine—Cough—Triamcinolone—multiple sclerosis	0.00106	0.00215	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Prednisolone—multiple sclerosis	0.00105	0.00213	CcSEcCtD
Carboprost Tromethamine—Hypertension—Triamcinolone—multiple sclerosis	0.00104	0.00212	CcSEcCtD
Carboprost Tromethamine—Hypertension—Methylprednisolone—multiple sclerosis	0.00104	0.00212	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00104	0.00211	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCL13—multiple sclerosis	0.00104	0.0021	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCR1—multiple sclerosis	0.00104	0.0021	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00103	0.0021	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.00103	0.00209	CbGpPWpGaD
Carboprost Tromethamine—Myalgia—Triamcinolone—multiple sclerosis	0.00103	0.00209	CcSEcCtD
Carboprost Tromethamine—Vomiting—Azathioprine—multiple sclerosis	0.00103	0.00209	CcSEcCtD
Carboprost Tromethamine—Myalgia—Methylprednisolone—multiple sclerosis	0.00103	0.00209	CcSEcCtD
Carboprost Tromethamine—Anxiety—Methylprednisolone—multiple sclerosis	0.00102	0.00208	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Methotrexate—multiple sclerosis	0.00102	0.00208	CcSEcCtD
Carboprost Tromethamine—Rash—Azathioprine—multiple sclerosis	0.00102	0.00208	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Azathioprine—multiple sclerosis	0.00102	0.00207	CcSEcCtD
Carboprost Tromethamine—Flushing—Prednisone—multiple sclerosis	0.00102	0.00207	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCL13—multiple sclerosis	0.00102	0.00205	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCR1—multiple sclerosis	0.00102	0.00205	CbGpPWpGaD
Carboprost Tromethamine—Headache—Azathioprine—multiple sclerosis	0.00101	0.00206	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.00101	0.00205	CbGpPWpGaD
Carboprost Tromethamine—Angioedema—Dexamethasone—multiple sclerosis	0.001	0.00204	CcSEcCtD
Carboprost Tromethamine—Angioedema—Betamethasone—multiple sclerosis	0.001	0.00204	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000987	0.00201	CcSEcCtD
Carboprost Tromethamine—Vertigo—Dexamethasone—multiple sclerosis	0.000986	0.00201	CcSEcCtD
Carboprost Tromethamine—Vertigo—Betamethasone—multiple sclerosis	0.000986	0.00201	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000985	0.002	CcSEcCtD
Carboprost Tromethamine—Syncope—Dexamethasone—multiple sclerosis	0.000984	0.002	CcSEcCtD
Carboprost Tromethamine—Syncope—Betamethasone—multiple sclerosis	0.000984	0.002	CcSEcCtD
Carboprost Tromethamine—Infection—Triamcinolone—multiple sclerosis	0.00098	0.00199	CcSEcCtD
Carboprost Tromethamine—Infection—Methylprednisolone—multiple sclerosis	0.000978	0.00199	CcSEcCtD
Carboprost Tromethamine—Shock—Triamcinolone—multiple sclerosis	0.000971	0.00197	CcSEcCtD
Carboprost Tromethamine—Shock—Methylprednisolone—multiple sclerosis	0.000969	0.00197	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000964	0.00196	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000964	0.00196	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Methotrexate—multiple sclerosis	0.000964	0.00196	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000964	0.00196	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Prednisolone—multiple sclerosis	0.000964	0.00196	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Triamcinolone—multiple sclerosis	0.000963	0.00196	CcSEcCtD
Carboprost Tromethamine—Nausea—Azathioprine—multiple sclerosis	0.000961	0.00195	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000961	0.00195	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000954	0.00194	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000952	0.00194	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TAGAP—multiple sclerosis	0.000951	0.00192	CbGpPWpGaD
Carboprost Tromethamine—Hypertension—Dexamethasone—multiple sclerosis	0.000947	0.00193	CcSEcCtD
Carboprost Tromethamine—Hypertension—Betamethasone—multiple sclerosis	0.000947	0.00193	CcSEcCtD
Carboprost Tromethamine—Asthenia—Mitoxantrone—multiple sclerosis	0.000939	0.00191	CcSEcCtD
Carboprost Tromethamine—Myalgia—Dexamethasone—multiple sclerosis	0.000934	0.0019	CcSEcCtD
Carboprost Tromethamine—Myalgia—Betamethasone—multiple sclerosis	0.000934	0.0019	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCL5—multiple sclerosis	0.000932	0.00188	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TAGAP—multiple sclerosis	0.000931	0.00188	CbGpPWpGaD
Carboprost Tromethamine—Anxiety—Dexamethasone—multiple sclerosis	0.000931	0.00189	CcSEcCtD
Carboprost Tromethamine—Anxiety—Betamethasone—multiple sclerosis	0.000931	0.00189	CcSEcCtD
Carboprost Tromethamine—Pain—Prednisolone—multiple sclerosis	0.000918	0.00187	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCL5—multiple sclerosis	0.000912	0.00184	CbGpPWpGaD
Carboprost Tromethamine—Vision blurred—Prednisone—multiple sclerosis	0.000901	0.00183	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000899	0.00183	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000897	0.00182	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000895	0.00182	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000895	0.00182	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000895	0.00182	CcSEcCtD
Carboprost Tromethamine—Infection—Betamethasone—multiple sclerosis	0.00089	0.00181	CcSEcCtD
Carboprost Tromethamine—Infection—Dexamethasone—multiple sclerosis	0.00089	0.00181	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000886	0.0018	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000884	0.0018	CcSEcCtD
Carboprost Tromethamine—Shock—Dexamethasone—multiple sclerosis	0.000881	0.00179	CcSEcCtD
Carboprost Tromethamine—Shock—Betamethasone—multiple sclerosis	0.000881	0.00179	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Triamcinolone—multiple sclerosis	0.00088	0.00179	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Betamethasone—multiple sclerosis	0.000874	0.00178	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Dexamethasone—multiple sclerosis	0.000874	0.00178	CcSEcCtD
Carboprost Tromethamine—Angioedema—Prednisone—multiple sclerosis	0.000873	0.00178	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000866	0.00176	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000866	0.00176	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000862	0.00174	CbGpPWpGaD
Carboprost Tromethamine—Vertigo—Prednisone—multiple sclerosis	0.000858	0.00175	CcSEcCtD
Carboprost Tromethamine—Syncope—Prednisone—multiple sclerosis	0.000857	0.00174	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Methotrexate—multiple sclerosis	0.000855	0.00174	CcSEcCtD
Carboprost Tromethamine—Pain—Triamcinolone—multiple sclerosis	0.000844	0.00172	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000843	0.0017	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000843	0.0017	CbGpPWpGaD
Carboprost Tromethamine—Loss of consciousness—Prednisone—multiple sclerosis	0.00084	0.00171	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCR5—multiple sclerosis	0.000839	0.0017	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Mitoxantrone—multiple sclerosis	0.000832	0.00169	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—S1PR1—multiple sclerosis	0.000831	0.00168	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000825	0.00167	CbGpPWpGaD
Carboprost Tromethamine—Hypertension—Prednisone—multiple sclerosis	0.000825	0.00168	CcSEcCtD
Carboprost Tromethamine—Rash—Mitoxantrone—multiple sclerosis	0.000825	0.00168	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000824	0.00168	CcSEcCtD
Carboprost Tromethamine—Chills—Methotrexate—multiple sclerosis	0.000823	0.00167	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCR5—multiple sclerosis	0.000822	0.00166	CbGpPWpGaD
Carboprost Tromethamine—Headache—Mitoxantrone—multiple sclerosis	0.000819	0.00167	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000816	0.00166	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000816	0.00166	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—S1PR1—multiple sclerosis	0.000814	0.00164	CbGpPWpGaD
Carboprost Tromethamine—Myalgia—Prednisone—multiple sclerosis	0.000813	0.00165	CcSEcCtD
Carboprost Tromethamine—Anxiety—Prednisone—multiple sclerosis	0.000811	0.00165	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GPC5—multiple sclerosis	0.000809	0.00163	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000804	0.00164	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Betamethasone—multiple sclerosis	0.000804	0.00164	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GPC5—multiple sclerosis	0.000792	0.0016	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000791	0.00161	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000784	0.00158	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Triamcinolone—multiple sclerosis	0.00078	0.00159	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Prednisone—multiple sclerosis	0.00078	0.00159	CcSEcCtD
Carboprost Tromethamine—Nausea—Mitoxantrone—multiple sclerosis	0.000777	0.00158	CcSEcCtD
Carboprost Tromethamine—Infection—Prednisone—multiple sclerosis	0.000775	0.00158	CcSEcCtD
Carboprost Tromethamine—Back pain—Methotrexate—multiple sclerosis	0.000772	0.00157	CcSEcCtD
Carboprost Tromethamine—Shock—Prednisone—multiple sclerosis	0.000767	0.00156	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000767	0.00155	CbGpPWpGaD
Carboprost Tromethamine—Pain—Betamethasone—multiple sclerosis	0.000766	0.00156	CcSEcCtD
Carboprost Tromethamine—Pain—Dexamethasone—multiple sclerosis	0.000766	0.00156	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Prednisone—multiple sclerosis	0.000761	0.00155	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000757	0.00153	CbGpPWpGaD
Carboprost Tromethamine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000754	0.00153	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Methotrexate—multiple sclerosis	0.000753	0.00153	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000741	0.0015	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCL3—multiple sclerosis	0.000739	0.00149	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCR2—multiple sclerosis	0.000736	0.00149	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000727	0.00148	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000725	0.00148	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCL3—multiple sclerosis	0.000724	0.00146	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000721	0.00146	CbGpPWpGaD
Carboprost Tromethamine—Vertigo—Methotrexate—multiple sclerosis	0.000717	0.00146	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PTGER4—multiple sclerosis	0.000712	0.00144	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00071	0.00145	CcSEcCtD
Carboprost Tromethamine—Dizziness—Prednisolone—multiple sclerosis	0.00071	0.00144	CcSEcCtD
Carboprost Tromethamine—Asthenia—Triamcinolone—multiple sclerosis	0.000708	0.00144	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Betamethasone—multiple sclerosis	0.000708	0.00144	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000708	0.00144	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RGS1—multiple sclerosis	0.000707	0.00143	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Methylprednisolone—multiple sclerosis	0.000706	0.00144	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Prednisone—multiple sclerosis	0.0007	0.00142	CcSEcCtD
Carboprost Tromethamine—Cough—Methotrexate—multiple sclerosis	0.000697	0.00142	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000696	0.00141	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RGS1—multiple sclerosis	0.000692	0.0014	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCR3—multiple sclerosis	0.000687	0.00139	CbGpPWpGaD
Carboprost Tromethamine—Myalgia—Methotrexate—multiple sclerosis	0.00068	0.00138	CcSEcCtD
Carboprost Tromethamine—Chest pain—Methotrexate—multiple sclerosis	0.00068	0.00138	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CNR1—multiple sclerosis	0.000679	0.00137	CbGpPWpGaD
Carboprost Tromethamine—Rash—Prednisolone—multiple sclerosis	0.000677	0.00138	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Prednisolone—multiple sclerosis	0.000676	0.00138	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000674	0.00137	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000673	0.00136	CbGpPWpGaD
Carboprost Tromethamine—Headache—Prednisolone—multiple sclerosis	0.000672	0.00137	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GPR65—multiple sclerosis	0.00067	0.00135	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCR2—multiple sclerosis	0.000669	0.00135	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000665	0.00134	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000658	0.00133	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—POMC—multiple sclerosis	0.000656	0.00133	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GPR65—multiple sclerosis	0.000656	0.00133	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCR2—multiple sclerosis	0.000654	0.00132	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Triamcinolone—multiple sclerosis	0.000653	0.00133	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000652	0.00133	CcSEcCtD
Carboprost Tromethamine—Dizziness—Methylprednisolone—multiple sclerosis	0.000651	0.00132	CcSEcCtD
Carboprost Tromethamine—Infection—Methotrexate—multiple sclerosis	0.000647	0.00132	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000644	0.0013	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Dexamethasone—multiple sclerosis	0.000642	0.00131	CcSEcCtD
Carboprost Tromethamine—Asthenia—Betamethasone—multiple sclerosis	0.000642	0.00131	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—POMC—multiple sclerosis	0.000642	0.0013	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCL2—multiple sclerosis	0.000642	0.0013	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Prednisolone—multiple sclerosis	0.000637	0.0013	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00063	0.00128	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCL2—multiple sclerosis	0.000628	0.00127	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Triamcinolone—multiple sclerosis	0.000627	0.00128	CcSEcCtD
Carboprost Tromethamine—Vomiting—Methylprednisolone—multiple sclerosis	0.000626	0.00127	CcSEcCtD
Carboprost Tromethamine—Rash—Triamcinolone—multiple sclerosis	0.000622	0.00127	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Triamcinolone—multiple sclerosis	0.000622	0.00126	CcSEcCtD
Carboprost Tromethamine—Rash—Methylprednisolone—multiple sclerosis	0.000621	0.00126	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Methylprednisolone—multiple sclerosis	0.00062	0.00126	CcSEcCtD
Carboprost Tromethamine—Headache—Triamcinolone—multiple sclerosis	0.000618	0.00126	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CNR1—multiple sclerosis	0.000617	0.00125	CbGpPWpGaD
Carboprost Tromethamine—Headache—Methylprednisolone—multiple sclerosis	0.000617	0.00125	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Prednisone—multiple sclerosis	0.000616	0.00125	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCR1—multiple sclerosis	0.000613	0.00124	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCL13—multiple sclerosis	0.000613	0.00124	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000613	0.00125	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Betamethasone—multiple sclerosis	0.000613	0.00125	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000612	0.00124	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CNR1—multiple sclerosis	0.000604	0.00122	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCR1—multiple sclerosis	0.0006	0.00121	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCL13—multiple sclerosis	0.0006	0.00121	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000599	0.00121	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000594	0.00121	CcSEcCtD
Carboprost Tromethamine—Dizziness—Betamethasone—multiple sclerosis	0.000592	0.0012	CcSEcCtD
Carboprost Tromethamine—Dizziness—Dexamethasone—multiple sclerosis	0.000592	0.0012	CcSEcCtD
Carboprost Tromethamine—Nausea—Triamcinolone—multiple sclerosis	0.000586	0.00119	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Methotrexate—multiple sclerosis	0.000585	0.00119	CcSEcCtD
Carboprost Tromethamine—Nausea—Methylprednisolone—multiple sclerosis	0.000585	0.00119	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Methotrexate—multiple sclerosis	0.000581	0.00118	CcSEcCtD
Carboprost Tromethamine—Somnolence—Methotrexate—multiple sclerosis	0.000579	0.00118	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Prednisone—multiple sclerosis	0.000575	0.00117	CcSEcCtD
Carboprost Tromethamine—Vomiting—Dexamethasone—multiple sclerosis	0.000569	0.00116	CcSEcCtD
Carboprost Tromethamine—Vomiting—Betamethasone—multiple sclerosis	0.000569	0.00116	CcSEcCtD
Carboprost Tromethamine—Rash—Dexamethasone—multiple sclerosis	0.000565	0.00115	CcSEcCtD
Carboprost Tromethamine—Rash—Betamethasone—multiple sclerosis	0.000565	0.00115	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Dexamethasone—multiple sclerosis	0.000564	0.00115	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Betamethasone—multiple sclerosis	0.000564	0.00115	CcSEcCtD
Carboprost Tromethamine—Headache—Dexamethasone—multiple sclerosis	0.000561	0.00114	CcSEcCtD
Carboprost Tromethamine—Headache—Betamethasone—multiple sclerosis	0.000561	0.00114	CcSEcCtD
Carboprost Tromethamine—Asthenia—Prednisone—multiple sclerosis	0.00056	0.00114	CcSEcCtD
Carboprost Tromethamine—Pain—Methotrexate—multiple sclerosis	0.000557	0.00113	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCL10—multiple sclerosis	0.000555	0.00112	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000544	0.0011	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Prednisone—multiple sclerosis	0.000534	0.00109	CcSEcCtD
Carboprost Tromethamine—Nausea—Dexamethasone—multiple sclerosis	0.000532	0.00108	CcSEcCtD
Carboprost Tromethamine—Nausea—Betamethasone—multiple sclerosis	0.000532	0.00108	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCL5—multiple sclerosis	0.000527	0.00106	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Prednisone—multiple sclerosis	0.000516	0.00105	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000515	0.00104	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Methotrexate—multiple sclerosis	0.000515	0.00105	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000506	0.00102	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Prednisone—multiple sclerosis	0.000496	0.00101	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000495	0.001	CbGpPWpGaD
Carboprost Tromethamine—Rash—Prednisone—multiple sclerosis	0.000492	0.001	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Prednisone—multiple sclerosis	0.000491	0.000999	CcSEcCtD
Carboprost Tromethamine—Headache—Prednisone—multiple sclerosis	0.000489	0.000994	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Methotrexate—multiple sclerosis	0.00048	0.000977	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCL5—multiple sclerosis	0.000478	0.000967	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCR5—multiple sclerosis	0.000474	0.000959	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCL5—multiple sclerosis	0.000468	0.000946	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Methotrexate—multiple sclerosis	0.000468	0.000951	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000468	0.000945	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000464	0.000939	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Prednisone—multiple sclerosis	0.000463	0.000942	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000458	0.000925	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Methotrexate—multiple sclerosis	0.000446	0.000907	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCL3—multiple sclerosis	0.000437	0.000883	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Methotrexate—multiple sclerosis	0.000431	0.000877	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCR5—multiple sclerosis	0.000431	0.000871	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCL3—multiple sclerosis	0.000427	0.000864	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL2RA—multiple sclerosis	0.000425	0.000858	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCR5—multiple sclerosis	0.000422	0.000852	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTGER4—multiple sclerosis	0.00042	0.00085	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000416	0.00084	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Methotrexate—multiple sclerosis	0.000414	0.000843	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PGR—multiple sclerosis	0.000414	0.000837	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTGER4—multiple sclerosis	0.000411	0.000832	CbGpPWpGaD
Carboprost Tromethamine—Rash—Methotrexate—multiple sclerosis	0.000411	0.000836	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Methotrexate—multiple sclerosis	0.000411	0.000835	CcSEcCtD
Carboprost Tromethamine—Headache—Methotrexate—multiple sclerosis	0.000408	0.00083	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCR3—multiple sclerosis	0.000406	0.000821	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PGR—multiple sclerosis	0.000405	0.000819	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CD28—multiple sclerosis	0.000402	0.000813	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCR3—multiple sclerosis	0.000397	0.000803	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCR2—multiple sclerosis	0.000395	0.000798	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CD28—multiple sclerosis	0.000394	0.000796	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Methotrexate—multiple sclerosis	0.000387	0.000787	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCR2—multiple sclerosis	0.000387	0.000781	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—POMC—multiple sclerosis	0.000371	0.000749	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CNR1—multiple sclerosis	0.000364	0.000737	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—POMC—multiple sclerosis	0.000363	0.000734	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CNR1—multiple sclerosis	0.000357	0.000721	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—POMC—multiple sclerosis	0.000337	0.000681	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—POMC—multiple sclerosis	0.00033	0.000666	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCL2—multiple sclerosis	0.000329	0.000666	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCL10—multiple sclerosis	0.000328	0.000663	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCL2—multiple sclerosis	0.000322	0.000652	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCL10—multiple sclerosis	0.000321	0.000649	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—TYK2—multiple sclerosis	0.000299	0.000605	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—TYK2—multiple sclerosis	0.000293	0.000592	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CD86—multiple sclerosis	0.000287	0.00058	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCL5—multiple sclerosis	0.000282	0.000571	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CD86—multiple sclerosis	0.000281	0.000568	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCL5—multiple sclerosis	0.000276	0.000559	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—IL2—multiple sclerosis	0.000274	0.000554	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—IL2—multiple sclerosis	0.000268	0.000542	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SPP1—multiple sclerosis	0.000262	0.000529	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SPP1—multiple sclerosis	0.000256	0.000518	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCR5—multiple sclerosis	0.000254	0.000514	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL2RA—multiple sclerosis	0.000251	0.000507	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCR5—multiple sclerosis	0.000249	0.000504	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL2—multiple sclerosis	0.000249	0.000503	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL2RA—multiple sclerosis	0.000245	0.000496	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL2—multiple sclerosis	0.000244	0.000492	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APOE—multiple sclerosis	0.000232	0.000468	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APOE—multiple sclerosis	0.000227	0.000458	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CD80—multiple sclerosis	0.000209	0.000423	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CD80—multiple sclerosis	0.000205	0.000414	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—POMC—multiple sclerosis	0.000199	0.000402	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—POMC—multiple sclerosis	0.000195	0.000394	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCL2—multiple sclerosis	0.000195	0.000393	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCL2—multiple sclerosis	0.00019	0.000385	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—MAPK1—multiple sclerosis	0.00019	0.000385	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000186	0.000377	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TYK2—multiple sclerosis	0.000177	0.000357	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TYK2—multiple sclerosis	0.000173	0.00035	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL2—multiple sclerosis	0.000147	0.000297	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL6—multiple sclerosis	0.000146	0.000296	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL2—multiple sclerosis	0.000144	0.000291	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL6—multiple sclerosis	0.000143	0.000289	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MMP9—multiple sclerosis	0.000139	0.000281	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MMP9—multiple sclerosis	0.000136	0.000275	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—STAT3—multiple sclerosis	0.000124	0.00025	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—STAT3—multiple sclerosis	0.000121	0.000245	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MYC—multiple sclerosis	0.000115	0.000232	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TGFB1—multiple sclerosis	0.000115	0.000232	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MYC—multiple sclerosis	0.000113	0.000227	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MAPK1—multiple sclerosis	0.000112	0.000227	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TGFB1—multiple sclerosis	0.000112	0.000227	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MAPK1—multiple sclerosis	0.00011	0.000223	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL6—multiple sclerosis	8.64e-05	0.000175	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL6—multiple sclerosis	8.46e-05	0.000171	CbGpPWpGaD
